Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.5K
Leaky Scanning02:28

Leaky Scanning

5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipose-Cardiac Crosstalk in Obesity-Related Atrial Fibrillation: The Emerging Role of Extracellular Vesicles.

JACC. Basic to translational science·2026
Same author

Stroke-induced immunosuppression is associated with brain injury and poor outcomes in patients receiving intravenous thrombolysis: A multicenter prospective cohort study.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Non-pharmacological therapies for breast cancer-related lymphedema: a systematic review and network meta-analysis based on randomized controlled trials.

Frontiers in oncology·2026
Same author

Sodium alginate/modified gelatin photothermal antibacterial hydrogel with mesoporous polydopamine-loaded α-N-thiosemicarbazone for promoting wound healing.

International journal of biological macromolecules·2026
Same author

Evaluation of four automated nucleic acid testing systems for the ultrasensitive quantification of hepatitis B virus.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026
Same author

Hyperinvasive and quinolone-resistant meningococci cc4821 achieved immune evasion through capsule switching.

BMC microbiology·2026
Same journal

Corrigendum to 'A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)' [Biomed. Pharmacother. 181 (2024) 117706].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Comparative in vitro evaluation of fourth-generation anti-GPC3 CAR T-cells in hepatocellular carcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Wnt activation during epileptogenesis prevents pathological immature dentate granule cell morphological changes in animal models of unilateral and bilateral temporal lobe epilepsy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Related Experiment Video

Updated: Aug 14, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development.

Shilin Zhou1, Panpan Lv2, Mingxue Li1

  • 1Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 18, 2023
PubMed
Summary
This summary is machine-generated.

This review details the SARS-CoV-2 envelope (E) protein, a key target for COVID-19 therapies. Understanding its role in viral replication and pathogenesis aids in developing new antiviral drugs.

Keywords:
Envelope proteinLife cycleMutationsPathogenesisPotential therapySARS-CoV-2

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

548

Related Experiment Videos

Last Updated: Aug 14, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

548

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitates urgent therapeutic development.
  • Viral structural proteins, including the SARS-CoV-2 envelope (E) protein, are critical drug targets.
  • The E protein is integral to the virus life cycle and pathogenesis.

Purpose of the Study:

  • To provide a comprehensive overview of the SARS-CoV-2 E protein.
  • To explore its role in viral replication and pathogenic mechanisms.
  • To summarize current therapeutic strategies targeting the E protein.

Main Methods:

  • Comparative analysis of SARS-CoV-2 E protein amino acid sequence with other human coronaviruses.
  • Review of existing literature on the E protein's function in the viral life cycle.
  • Synthesis of data on potential drugs targeting the E protein and the impact of mutations.

Main Results:

  • The E protein's sequence and its comparison with homologous proteins.
  • Detailed exploration of the E protein's involvement in viral pathogenesis.
  • Summary of identified potential therapeutic agents and the implications of E protein mutations.

Conclusions:

  • The SARS-CoV-2 E protein is a crucial factor in viral pathogenesis and a promising target for drug development.
  • A consolidated knowledge system of the E protein is vital for combating COVID-19 and future coronavirus outbreaks.